Skip to main content




Associated Conditions

Paroxysmal Atrial Fibrillation

Principal Investigator


Biosense Webster

The purpose of this study is to provide information about the safety and long-term effectiveness of the QDOT MICRO Catheter for the treatment of subjects with Paroxysmal Atrial Fibrillation (PAF) who have failed at least one antiarrythmic drug (medication to treat symptoms of PAF). The QDOT MICRO Catheter is an investigational device that has not been approved by the FDA for the treatment of PAF.

This study is currently enrolling.